ALIPAY
16.9.2021 04:29:11 CEST | Business Wire | Press release
Fintech training platform 10x1000 Tech for Inclusion announced that it will deepen its collaborations with partners worldwide, working with leading global organizations, tech investors, and industry organizations to offer a program that enables aspiring practitioners to learn from global experts at their own pace.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210915006200/en/
Available from October through grants to over 1,000 learners, the Fintech Foundation Program Flex is a fully online certificate program providing practitioners with the mindset, knowledge and skills to become drivers of digital economic growth, according to 10x1000, a global and philanthropic fintech training initiative launched jointly by the International Finance Corporation (IFC), a member of the World Bank Group, and Alipay in 2018.
Flex learners will be recruited through partners such as the IFC (including the SME Finance Forum), United Nations Economic Commission for Africa, Dubai International Financial Centre, Malaysia Digital Economy Corporation, KPMG and fintech associations from Hong Kong, Malaysia, the Philippines, Thailand, and Singapore. (See table for a full list of 10X1000 partners)
“We are delighted to join hands with global partners to bring the 10x1000 training platform to learners worldwide, as we seek innovative approaches to meeting a common goal of bridging the digital skills gap, particularly in communities that need it the most,” said Eric Jing, Chairman and CEO of Ant Group, owner and operator of digital payments platform Alipay. “I am excited that learners from 10x1000’s new Flex program will gain the fintech knowledge they need to support their communities, and help bring us closer to meeting the UN Sustainable Development Goals (SDGs).”
“IFC has been a steadfast supporter of digital innovations that foster financial inclusion. As nations emerge from the Covid-19 pandemic, the world is in need of more visionary fintech leaders to drive such innovation and expand financial access,” said Qamar Saleem, Regional Manager for Advisory Services, Financial Institutions Group, Asia and Pacific, IFC. “We believe 10x1000’s Flex program will bring distinct value to complement existing educational resources with a flexible curriculum that draws on practical experience of leading fintech practitioners across regions.”
Through eight recorded video lectures, attendees of the new Flex program will hear directly from tech entrepreneurs, senior leaders at Ant and other fintech firms as well as distinguished scholars, sharing their first-hand knowledge on topics ranging from ‘the tech behind fintech’ and best practices in leveraging technology to solve real business problems.
Training content provided by 10x1000 is being guided by a Curriculum Steering Committee (CSC), an advisory body responsible for ensuring the quality and effectiveness of the curriculum. The current committee is composed of global experts from industry, academia, and international financial institutions.
Going forward, 10x1000 will also work with partners and alumni to cultivate a global fintech community, creating a vibrant platform that provides opportunities for willing organizations and individuals to contribute to global financial inclusion.
About 10x1000
10x1000 Tech for Inclusion is an open and global fintech training platform that enables learners to become drivers of digital economic growth. Its mission is to train 1,000 emerging talents and tech leaders each year for the next ten years. 10x1000 is a philanthropic initiative launched jointly by the International Finance Corporation (IFC), a member of the World Bank Group, and Alipay in 2018.
** 10x1000 Tech for Inclusion Partners List **
Founding Partners
1. Alipay (Alipay)
2. IFC (International Finance Corporation)
Global Organizations
1. UNECA (United Nations Economic Commission for Africa)
2. UNWFP (United Nations World Food Programme)
3. SME Finance Forum (SME Finance Forum, Managed by the IFC)
Regional-Country Industry Organizations
1. Africa’s Business Heroes (ABH)
2. DIFC (Dubai International Financial Centre)
3. FTAHK (FinTech Association of Hong Kong)
4. FAOM (FinTech Association of Malaysia)
5. Fintech Alliance PH Inc (Fintech Alliance.ph)
6. MDEC (Malaysia Digital Economy Corporation)
7. MFTA (MENA Fintech Association)
8. SFA (Singapore FinTech Association)
9. SLT (She Loves Tech)
10. TFA (Thai Fintech Association)
Professional Services/Investors
1. BAce Capital (BAce Capital)
2. Gobi Partners (Gobi Partners)
3. KPMG (KPMG)
4. 917Ventures (917Ventures)
** 10x1000 Curriculum Steering Committee Members (2021) **
Nafez Dakkak
Executive Chairman, Edraak.org
Pooma Kimis
Director, Bernstein Autonomous
Qamar Saleem
Regional Industry Manager Asia & Pacific, Financial Institutions Group at International Finance Corporation (IFC)
Daniel Suen
Head of Strategy, International Education, General Manager, China Education, Wiley
View source version on businesswire.com: https://www.businesswire.com/news/home/20210915006200/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom